DRIVE-AB

[DRIVE-AB @DRIVE_AB]

'Vaccine uptake among children in England has fallen since start of pandemic.' Bad news for #AMR? https://t.co/5UomoLhYBk

[BSAC @BSACandJAC]

Are you following our @jac_amr account yet? Our fully #OpenAccess journal is the best place for all things related to #AMR and #AntibioticStewardship!

[DRIVE-AB @DRIVE_AB]

Look at #AMR from a different perspective🔎

Our FREE course, Tackling Antimicrobial Resistance: A Social Science Approach, explores how different cultures, customs and habits should all be considered to help #stopsuperbugs

Registration open now! https://t.co/E893K2PHdz

[Innovative Health Initiative @IHIEurope]

Our @DRIVE_AB project's final report recommends a mix of push & pull incentives to stimulate #antibiotic development.
Read the report https://t.co/pGLIaTjN6e
Read the project's press release https://t.co/nzfqulB2r6
#AntimicrobialResistance #CarryTheTorch #InvestEUresearch

[DRIVE-AB @DRIVE_AB]

DRIVE-AB consortium publishes final report on revitalizing the antibiotic pipeline, available at https://t.co/Kibp6xW2iR

[European Biotech @EuroBiotechNews]

Want to meet #AMR experts to discuss how to further support #SME-driven innovation in the fight against #AntibioticResistance? Register now for #BerlinConference in March 2018: https://t.co/2lJaRial0h @UU_University @BachmannTill @EdinburghUni @DRIVE_AB @ND4BB_ENABLE

[DRIVE-AB @DRIVE_AB]

A very concise summary of 4 recommended incentives from @DRIVE_AB to drive antibiotic R&D https://t.co/nhHsxMjgtd

[John H. Rex, MD @JohnRex_NewAbx]

I've posted my slide summary of DRIVE-AB's 4 recommended incentives: grants, pipeline coordination, MERs, continuity https://t.co/1ZFkTnYn3S

[Kevin Outterson @koutterson]

@DRIVE_AB @DRIVE_AB has worked for 3 years to design antibiotic pull incentives - we need these to be implemented quickly

[DRIVE-AB @DRIVE_AB]

On behalf of @DRIVE_AB - a big thank you to all of the delegates & participants who made the #DRIVEAB2017 conference this week a success!

[DRIVE-AB @DRIVE_AB]

Full details of @DRIVE_AB recommendations will be available with our final report January 2018 https://t.co/wK9dmdBQ94

[Damiano de Felice @damidefelice]

How should a market entry reward for new antibiotics look like? David Findlay @GSK presents the recommendations from @DRIVE_AB. #DRIVEAB2017

[Damiano de Felice @damidefelice]

How should a market entry reward for new antibiotics look like? David Findlay @GSK presents the recommendations from @DRIVE_AB. #DRIVEAB2017

[DASON @DASON_duke]

Incredible news for the global campaign against #AntibioticResistance #AMR @DRIVE_AB @DukeGHI @CIDRAP_ASP https://t.co/hw5jTtbcts

[DRIVE-AB @DRIVE_AB]

The final panel kicks off - what is the way forward and how do we get there? #DRIVEAB2017

[DRIVE-AB @DRIVE_AB]

'How do we change the net present value calculation of antibiotics in pharma to improve prioritization and decision making?' Steve Projan

[DRIVE-AB @DRIVE_AB]

Lively, informative discussions on this panel about MER vs value-based pricing and how to solve the broken market #DRIVEAB2017

[DRIVE-AB @DRIVE_AB]

Gregory Daniel from @dukemargolis tells us about their work looking at model options in the US

[DRIVE-AB @DRIVE_AB]

"Market entry rewards need be targeted, sustainable, transparent, and sufficient." #DRIVEAB2017

[DRIVE-AB @DRIVE_AB]

David Findlay starts off the afternoon session of #DRIVEAB2017 by wading into the thick of it - the details of our recommended options

[DRIVE-AB @DRIVE_AB]

EC, BARDA, Wellcome, ENABLE, & Helmholtz Center coming together at #DRIVEAB2017 to discuss how to ensure sustainable innovation

[NICE @NICEComms]

How can young people help tackle antibiotic resistance?Join us at #Expo17NHS next week and we'll explain all: https://t.co/pTimeFIBC6 #AMR